MIS Sacroiliac Joint Fusion Market Size & Growth Forecast 2027–2036, By Segments (Approach, Product, End-use, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
MIS Sacroiliac Joint Fusion Market size was valued at USD 1.05 Billion in 2026 and is anticipated to grow at 12.58% CAGR from 2027 to 2036, surpassing USD 3.43 Billion by 2036. The industry revenue for 2027 is calculated at USD 1.16 Billion.
Get more details on this report
Request Free Sample ReportMIS Sacroiliac Joint Fusion Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026 due to advanced healthcare infrastructure, established minimally invasive procedure adoption, specialized facilities, and experienced clinicians.
- Asia Pacific is expanding as healthcare infrastructure, specialist training, and access to advanced orthopedic procedures improve alongside demand for minimally invasive treatments.
Segment Momentum
- Implants dominated with a 61.73% share in 2026 because they enable durable joint stabilization, improved fusion outcomes, and enhanced minimally invasive procedure effectiveness.
- The anterior approach is the fastest-growing segment as improved imaging guidance and surgical techniques support individualized planning, better implant placement, and broader minimally invasive treatment adoption.
Market Expansion Drivers
- Rising geriatric population increasing prevalence of sacroiliac joint dysfunction and chronic pain cases
- Growing adoption of minimally invasive spinal procedures improving patient recovery and surgical outcomes
- Technological advancements in implant systems enhancing precision and success rates in joint fusion procedures
Leading Market Participants
- Major companies in the MIS sacroiliac joint fusion market include SI-BONE, Inc. (United States), Medtronic plc (Ireland), Globus Medical, Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), Orthofix Medical Inc. (United States), PainTEQ (United States), Life Spine, Inc. (United States), SIGNUS Medizintechnik GmbH (Germany), CoreLink Surgical (United States), Xtant Medical Holdings, Inc. (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.05 Billion
- 2027 Estimated Market Size: USD 1.16 Billion
- Projected Market Size: USD 3.43 Billion by 2036
- Growth Forecast: 12.58% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Dorsal (Approach) | Implants (Product) | Hospitals (End-use) | Degenerative Sacroiliitis (Indication)
- Emerging Opportunity Segment: Anterior (Approach) | Implants (Product) | Ambulatory Surgical Centers (End-use) | Sacroiliac Joint Dysfunction (Indication)
Market Growth Drivers and Industry Trends
Rising geriatric population increasing prevalence of sacroiliac joint dysfunction and chronic pain cases
The growing proportion of older adults worldwide is contributing to a higher incidence of degenerative musculoskeletal disorders, which will drive the MIS sacroiliac joint fusion market growth. Aging is closely associated with progressive wear of the sacroiliac joint, reduced joint stability, and chronic lower back pain, increasing the number of patients seeking effective long-term treatment options. As conservative therapies may provide limited relief for persistent sacroiliac joint dysfunction, healthcare providers are increasingly evaluating minimally invasive fusion procedures for appropriately selected patients. Greater awareness of age-related spinal conditions and improved diagnostic capabilities are also supporting earlier identification of sacroiliac joint disorders, leading to broader utilization of targeted surgical interventions in orthopedic and spine care settings.
Growing adoption of minimally invasive spinal procedures improving patient recovery and surgical outcomes
A strong preference for less invasive surgical techniques is creating favorable conditions for the MIS sacroiliac joint fusion market as clinicians prioritize procedures that minimize tissue disruption while enhancing patient recovery. Minimally invasive approaches are designed to reduce operative trauma, shorten hospital stays, and facilitate faster postoperative rehabilitation compared with conventional open surgeries. These advantages are particularly valuable for patients with chronic sacroiliac joint pain who seek effective treatment with reduced procedural burden. Healthcare systems are also supporting minimally invasive techniques because they can improve workflow efficiency, optimize resource utilization, and contribute to more predictable recovery pathways across spine surgery programs.
Technological advancements in implant systems enhancing precision and success rates in joint fusion procedures
Continuous innovation in implant design and surgical technologies is expected to propel the MIS sacroiliac joint fusion market growth by improving procedural accuracy and clinical performance. Modern implant systems are being developed with enhanced biomechanical stability, optimized anatomical compatibility, and instrumentation that supports precise placement during surgery. Advances in imaging guidance, navigation technologies, and specialized delivery instruments further assist surgeons in achieving accurate implant positioning while minimizing procedural complexity. These developments contribute to greater confidence in minimally invasive sacroiliac joint fusion by supporting consistent fixation and promoting effective bone fusion across a broad range of patient profiles.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising geriatric population increasing prevalence of sacroiliac joint dysfunction and chronic pain cases | 3.6% | High | North America, Europe | High | Near Term |
| Growing adoption of minimally invasive spinal procedures improving patient recovery and surgical outcomes | 3.8% | High | North America, Asia Pacific | High | Near Term |
| Technological advancements in implant systems enhancing precision and success rates in joint fusion procedures | 3.7% | High | North America, Europe | Emerging | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share of the MIS sacroiliac joint fusion market in 2026, reflecting the region's advanced healthcare infrastructure and established adoption of minimally invasive surgical procedures. Growing awareness of less invasive treatment approaches, combined with the availability of specialized surgical facilities and experienced clinicians, is supporting demand for sacroiliac joint fusion procedures. The region's focus on improving surgical outcomes while reducing procedural trauma and recovery requirements is also encouraging the use of minimally invasive techniques.
Asia Pacific (Fastest-Growing Region)
The MIS sacroiliac joint fusion market is expected to expand rapidly across Asia Pacific as healthcare infrastructure improves and access to advanced orthopedic procedures increases. Rising awareness of minimally invasive treatment options is encouraging healthcare providers to broaden their surgical capabilities, while improvements in hospital facilities and specialist training are supporting greater procedural adoption. Increasing demand for effective treatment of musculoskeletal disorders, together with healthcare modernization and expanding access to specialized care, is creating a favorable environment for market growth in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Outpatient Procedure FocusThe U.S. emphasizes minimally invasive sacroiliac joint fusion procedures that reduce hospital stays and support ambulatory care. Healthcare providers in the U.S. continue evaluating implants with improved surgical precision and clinical evidence for chronic pain management.
Germany 🇩🇪
Evidence-Based AdoptionGermany prioritizes clinically validated MIS sacroiliac joint fusion systems supported by long-term outcomes and surgeon training. Hospitals in Germany increasingly integrate advanced navigation and implant technologies to improve procedural consistency.
Japan 🇯🇵
Precision Surgical IntegrationJapan focuses on minimally invasive sacroiliac joint fusion solutions compatible with precision surgical workflows and aging patient care. Healthcare providers in Japan value implant reliability and techniques that minimize recovery time and procedural complexity.
South Korea 🇰🇷
Technology-Enabled OrthopedicsSouth Korea promotes advanced orthopedic procedures supported by imaging, navigation, and minimally invasive surgical platforms. Hospitals in South Korea are adopting sacroiliac joint fusion technologies that enhance procedural efficiency and patient recovery.
France 🇫🇷
Clinical Practice StandardizationFrance prioritizes standardized surgical protocols and clinically supported MIS sacroiliac joint fusion techniques. Healthcare institutions in France evaluate implant systems that align with quality-of-care objectives and consistent patient outcomes.
Italy 🇮🇹
Specialist Spine ExpansionItaly continues strengthening specialist spine centers performing minimally invasive sacroiliac joint fusion procedures. Surgeons in Italy increasingly favor implant systems that simplify workflows while supporting durable fixation and postoperative recovery.
MIS Sacroiliac Joint Fusion Market Share (%), by Approach, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApproach Segment Analysis: Dorsal (Largest Segment) vs Anterior (Fastest-Growing Segment)
The MIS sacroiliac joint fusion market was led by the dorsal approach segment, which accounted for 61.37% of the market share in 2026. The dorsal approach is widely preferred because it provides effective stabilization while minimizing disruption to surrounding anatomical structures. Its established clinical use, familiarity among spine surgeons, and compatibility with minimally invasive surgical techniques have contributed to consistent adoption, supporting improved patient recovery and procedural efficiency.
The anterior approach segment is anticipated to witness the fastest growth as advancements in surgical techniques and imaging guidance expand the range of minimally invasive treatment options available to clinicians. Growing emphasis on individualized surgical planning, improved implant placement, and enhanced patient outcomes is encouraging broader adoption of anterior procedures for appropriately selected cases.
Product Segment Analysis: Implants (Largest & Fastest-Growing Segment)
The implants segment dominated the MIS sacroiliac joint fusion market with a 61.73% share in 2026 while also representing the fastest-growing product category. Implants are fundamental to achieving durable sacroiliac joint stabilization and promoting long-term fusion outcomes. Continuous innovation in implant materials, design optimization, and minimally invasive delivery systems has improved procedural effectiveness, encouraging greater adoption among healthcare providers and supporting the segment's continued market leadership.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Holding the largest share of the MIS sacroiliac joint fusion market, the hospitals segment captured 57.24% in 2026. Hospitals remain the primary setting for minimally invasive spine procedures because they provide comprehensive surgical infrastructure, multidisciplinary clinical expertise, and advanced postoperative care. Their ability to manage complex cases and support specialized orthopedic and neurosurgical services continues to reinforce their leading position in the market.
The ambulatory surgical centers segment is expected to register the fastest growth as healthcare systems increasingly emphasize cost-effective, minimally invasive procedures performed in outpatient settings. Advances in surgical techniques, shorter recovery times, and growing patient preference for same-day treatment are encouraging more sacroiliac joint fusion procedures to be performed in ambulatory surgical centers while maintaining high standards of clinical care.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Approach | Dorsal, Anterior | Dorsal | Anterior |
| Product | Implants, Instruments & Equipment | Implants | Implants |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Indication | Trauma, Degenerative Sacroiliitis, Sacroiliac Joint Dysfunction | Degenerative Sacroiliitis | Sacroiliac Joint Dysfunction |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Major players in the MIS sacroiliac joint fusion market:
- SI-BONE, Inc. (United States)
- Medtronic plc (Ireland)
- Globus Medical, Inc. (United States)
- Zimmer Biomet Holdings, Inc. (United States)
- Orthofix Medical, Inc. (United States)
- PainTEQ (United States)
- Life Spine, Inc. (United States)
- SIGNUS Medizintechnik GmbH (Germany)
- CoreLink Surgical (United States)
- Xtant Medical Holdings, Inc. (United States)
Competition within the MIS sacroiliac joint fusion market is evolving around procedural consistency, implant design refinement, and the ability to improve minimally invasive surgical outcomes. Device developers are focusing on solutions that support surgeon adoption through easier handling, improved procedural workflows, and compatibility with evolving surgical techniques. As clinical expectations continue to rise, market positioning increasingly depends on demonstrating meaningful advantages in procedural efficiency and patient care while maintaining strong evidence and regulatory support.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| SI-BONE Inc. (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Globus Medical Inc. (United States) | |||||||
| Zimmer Biomet Holdings Inc. (United States) | |||||||
| Orthofix Medical Inc. (United States) | |||||||
| PainTEQ (United States) | |||||||
| Life Spine Inc. (United States) | |||||||
| SIGNUS Medizintechnik GmbH (Germany) | |||||||
| CoreLink Surgical (United States) | |||||||
| Xtant Medical Holdings Inc. (United States) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| CoreLink | Mar-23 | CoreLink received FDA clearance for its Siber Ti 3D-printed SI joint fusion system, featuring patented Mimetic Metal technology with macro, micro, and nano-level architecture designed to emulate natural bone structure and enhance clinical adoption. |
| CornerLoc | Oct-22 | CornerLoc unveiled the TransLoc 3D SI joint fusion system, introducing a hybrid construct that combines modular posterior implants and lateral oblique screws to advance sacroiliac joint fixation techniques and procedural versatility. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
MIS Sacroiliac Joint Fusion Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Young Adults, Middle-aged Adults, Older Adults |
| Surgeon Specialty | Orthopedic Surgeons, Neurosurgeons, Spine Surgeons |
| Care Pathway | Conservative Treatment Failure, Post-traumatic Management, Chronic Pain Management, Revision Surgery |
MIS Sacroiliac Joint Fusion Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Patient Selection & Procedure Adoption |
|
| Reimbursement & Health Economics |
|
| Hospital Procurement Dynamics |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How large is the MIS sacroiliac joint fusion market?
What is the expected industry size of MIS sacroiliac joint fusion by 2036?
Which clinical trends are accelerating adoption of minimally invasive sacroiliac joint fusion procedures?
How are technological advancements influencing MIS sacroiliac joint fusion procedures?
Why are implants the leading product segment in the MIS sacroiliac joint fusion market?
How is the anterior approach segment expanding in MIS sacroiliac joint fusion?
Why does North America lead the MIS sacroiliac joint fusion market?
What is driving MIS sacroiliac joint fusion growth in Asia Pacific?
Who holds a significant market share in the MIS sacroiliac joint fusion landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook